Abound Wealth Management Cytokinetics Inc Transaction History
Abound Wealth Management
- $312 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$641 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$521 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$470 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$345 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$269 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.11B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...